Sandu Pharmaceuticals standalone net profit declines 38.18% in the September 2017 quarter

Sales rise 43.60% to Rs 17.49 crore

Net profit of Sandu Pharmaceuticals declined 38.18% to Rs 0.34 crore in the quarter ended September 2017 as against Rs 0.55 crore during the previous quarter ended September 2016. Sales rose 43.60% to Rs 17.49 crore in the quarter ended September 2017 as against Rs 12.18 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales17.4912.18 44 OPM %4.699.20 -PBDT0.460.76 -39 PBT0.340.57 -40 NP0.340.55 -38

Powered by Capital Market - Live News